Cargando…

Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities

Lung cancer remains the first cause of cancer-related deaths worldwide. Thanks to the improvement in the knowledge of the biology of non-small cell lung cancer (NSCLC), patients’ survival has significantly improved. A growing number of targetable molecular alterations have been identified. Next-gene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lazzari, Chiara, Bulotta, Alessandra, Cangi, Maria Giulia, Bucci, Gabriele, Pecciarini, Lorenza, Bonfiglio, Silvia, Lorusso, Vincenza, Ippati, Stefania, Arrigoni, Gianluigi, Grassini, Greta, Doglioni, Claudio, Gregorc, Vanesa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765222/ https://www.ncbi.nlm.nih.gov/pubmed/33333743 http://dx.doi.org/10.3390/diagnostics10121092

Ejemplares similares

Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer
por: Gregorc, Vanesa, et al.
Publicado: (2021)

Gene Fusion Detection in NSCLC Routine Clinical Practice: Targeted-NGS or FISH?
por: Pecciarini, Lorenza, et al.
Publicado: (2023)

Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib
por: Lazzari, Chiara, et al.
Publicado: (2022)

Rapid targeted somatic mutation analysis of solid tumors in routine clinical diagnostics
por: Magliacane, Gilda, et al.
Publicado: (2015)

History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature
por: Lazzari, Chiara, et al.
Publicado: (2021)

Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can!
por: Magliacane, Gilda, et al.
Publicado: (2022)

Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer
por: Lazzari, Chiara, et al.
Publicado: (2017)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma
por: Pontara, Andrea, et al.
Publicado: (2020)

Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
por: Carretta, Angelo, et al.
Publicado: (2020)

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
por: Lazzari, Chiara, et al.
Publicado: (2018)

PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review
por: Mirabile, Aurora, et al.
Publicado: (2019)

Uncommon Site of Metastasis and Prolonged Survival in Patients with Anaplastic Thyroid Carcinoma: A Systematic Review of the Literature
por: Mirabile, Aurora, et al.
Publicado: (2020)

Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies
por: Lazzari, Chiara, et al.
Publicado: (2023)

Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence
por: Mirabile, Aurora, et al.
Publicado: (2020)

Mechanisms of resistance to osimertinib
por: Lazzari, Chiara, et al.
Publicado: (2020)

A Journey on the Skin Microbiome: Pitfalls and Opportunities
por: Pistone, Dario, et al.
Publicado: (2021)

Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies
por: Petrelli, Fausto, et al.
Publicado: (2018)

Biobanking in Atherosclerotic Disease, Opportunities and Pitfalls
por: Scholtes, V.P.W, et al.
Publicado: (2011)

Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic Combinations
por: Niedbała, Marcin, et al.
Publicado: (2022)

Spontaneous Regression of Primary Melanoma and Multiple Melanocytic Nevi in a Patient With Metastatic Melanoma
por: Paolino, Giovanni, et al.
Publicado: (2020)

Practical and Ethical Considerations in Telehealth: Pitfalls and Opportunities
por: Hull, Sarah C., et al.
Publicado: (2022)

KRAS in NSCLC: State of the Art and Future Perspectives
por: Cascetta, Priscilla, et al.
Publicado: (2022)

Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies
por: Giovannini, Monica, et al.
Publicado: (2009)

Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer
por: Ciliberto, Gennaro, et al.
Publicado: (2022)

Qualitative methods and patient and public involvement in trials: opportunities and pitfalls
por: Hoddinott, Pat, et al.
Publicado: (2015)

High-throughput sequencing of the T-cell receptor repertoire: pitfalls and opportunities
por: Heather, James M, et al.
Publicado: (2017)

Twenty‐five years of confirmatory adaptive designs: opportunities and pitfalls
por: Bauer, Peter, et al.
Publicado: (2015)

More Light? Opportunities and Pitfalls in Digitalized Psychotherapy Process Research
por: Domhardt, Matthias, et al.
Publicado: (2021)

Rehabilitation of Neuromuscular Diseases During COVID-19: Pitfalls and Opportunities
por: Liguori, Sara, et al.
Publicado: (2021)

Ultrasound Imaging in Sport-Related Muscle Injuries: Pitfalls and Opportunities
por: Paoletta, Marco, et al.
Publicado: (2021)

Towards Social Media as DTx in Psychiatry? Current opportunities and pitfalls
por: Orsolini, L.
Publicado: (2023)

Pitfalls and Challenges in Oral Plasma Cell Mucositis: A Systematic Review
por: Coppola, Noemi, et al.
Publicado: (2022)

Immunotherapeutic Advances for NSCLC
por: Massafra, Marco, et al.
Publicado: (2021)

Early referral to palliative care in IPF – pitfalls and opportunities in clinical trials
por: Kalluri, Meena, et al.
Publicado: (2020)

Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 †
por: Malinowska, Barbara, et al.
Publicado: (2021)

In vitro human gut microbiota fermentation models: opportunities, challenges, and pitfalls
por: Isenring, Julia, et al.
Publicado: (2023)

Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls
por: Horak, Peter, et al.
Publicado: (2016)

Recent Radiomics Advancements in Breast Cancer: Lessons and Pitfalls for the Next Future
por: Pesapane, Filippo, et al.
Publicado: (2021)

NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer
por: Gregorc, Vanesa, et al.
Publicado: (2018)

Emergency Department Visits among Cancer Patients during SARS-CoV-2 Pandemic
por: Valsecchi, Davide, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3a833blohkicdp89nrrcai8h9p